Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Orchard Therapeutics

    NASDAQ: ORTX · Real-Time Price · USD
    16.70
    0.05 (0.30%)
    At close: Jan 23, 2024, 10:00 PM

    Orchard Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -150.66M -144.58M
    Depreciation & Amortization
    		 2.74M 2.33M
    Stock-Based Compensation
    		 16.01M 22.54M
    Other Working Capital
    		 29.98M 13.12M
    Other Non-Cash Items
    		 23M 10.56M
    Deferred Income Tax
    		 -3.28M 1.13M
    Change in Working Capital
    		 36.2M -17.06M
    Operating Cash Flow
    		 -75.99M -125.1M
    Capital Expenditures
    		 -6.51M -3.23M
    Cash Acquisitions
    		 n/a 887K
    Purchase of Investments
    		 -112.28M -263.88M
    Sales Maturities Of Investments
    		 201.39M 234.73M
    Other Investing Acitivies
    		 7.97M -671K
    Investing Cash Flow
    		 90.56M -32.16M
    Debt Repayment
    		 n/a n/a
    Common Stock Repurchased
    		 -19K -392K
    Dividend Paid
    		 n/a n/a
    Other Financial Acitivies
    		 -693K 158.07M
    Financial Cash Flow
    		 -693K 158.07M
    Net Cash Flow
    		 12.46M 777K
    Free Cash Flow
    		 -82.5M -128.33M

    Add to Watchlist